AGER and Alzheimer disease: The BBB is disrupted in AD via a series of complementary mechanisms such as sustained neuroinflammation, oxidative stress, and dysregulated autoimmunity, resulting in the downregulation of carriers such as P-gp and LRP1, concomitantly with the upregulation of RAGE and other influx transporters [59].